A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity

NCT06965413 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

285

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight
Overweight With One Weight Related Comorbidity

Interventions

DRUG: RO7204239
DRUG: RO7204239 Matching Placebo
DRUG: Tirzepatide

Sponsor

Hoffmann-La Roche